Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:steroidogenesis_inhibitor |
| gptkbp:ATCCode |
H02CA03
|
| gptkbp:CASNumber |
54-36-4
|
| gptkbp:discoveredBy |
gptkb:Ciba-Geigy
|
| gptkbp:discoveredIn |
1958
|
| gptkbp:eliminationHalfLife |
2 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:hasMolecularFormula |
C14H14N2O
|
| gptkbp:IUPACName |
2-methyl-1,2-di(pyridin-3-yl)propan-1-one
|
| gptkbp:KEGGID |
D00437
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits 11β-hydroxylase
|
| gptkbp:MeSH_ID |
D008756
|
| gptkbp:metabolism |
hepatic
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:PubChem_CID |
4166
4023 CHEMBL1411 DB01011 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting dizziness hypotension adrenal insufficiency |
| gptkbp:synonym |
Metopirone
|
| gptkbp:UNII |
8H672S4GWS
|
| gptkbp:usedFor |
gptkb:Cushing's_syndrome
diagnosis of adrenal insufficiency |
| gptkbp:bfsParent |
gptkb:MT-41
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Metyrapone
|